Effects of Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Artery Chemoembolization
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-80
SponsorTaichung Tzu Chi Hospital
About this trial
Effects of Antrodia cinnamomea on the hepatoma patients after Transcatheter hepatic artery chemoembolization
Eligibility criteria
Qualifiers
Sign the informed consent form
Aged between 20 and 80
Child-Pugh score class A, B
Serum bilirubin level ≤ 1.5 times the upper limit of normal, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels ≤ 2 times the upper limit of normal
Disqualifiers
Unwillingness to sign the informed consent form
Child-Pugh score class C
Patients with main portal vein thrombosis
Patients with diffuse liver tumors
Trial design
Treatments tested in this trial
- Antrodia cinnamomea
- placebo
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov